Current Assets
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value
CVS Health AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value increased by 253.0% to $10.08B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 107.2%, from $4.87B to $10.08B. Over 5 years (FY 2020 to FY 2025), AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value shows an upward trend with a 26.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ2 2019
Last reportedQ1 2026May 6, 2026
Metric ID:
afs_trading_securities_unrealized_loss_lt_12m_fvHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.02B | $4.24B | $6.80B | $12.50B | $15.83B | $16.97B | $14.23B | $7.37B | $7.48B | $6.50B | $1.93B | $4.58B | $6.04B | $871.00M | $7.51B | $4.87B | $2.51B | $1.78B | $2.86B | $10.08B |
| QoQ Change | — | +40.2% | +60.4% | +83.8% | +26.6% | +7.2% | -16.1% | -48.2% | +1.4% | -13.0% | -70.3% | +137.0% | +32.0% | -85.6% | +761.8% | -35.2% | -48.4% | -29.1% | +60.5% | +253.0% |
| YoY Change | — | — | — | — | +423.3% | +300.3% | +109.2% | -41.0% | -52.8% | -61.7% | -86.4% | -37.9% | -19.2% | -86.6% | +288.5% | +6.3% | -58.5% | +104.2% | -62.0% | +107.2% |
Range$871.00M – $16.97B
CAGR+28.9%
Avg YoY Growth+52.1%
Median YoY Growth-28.5%
Current Streak2 quarters growth
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value at Other Companies
Frequently Asked Questions
- What is CVS Health's afs and trading securities - unrealized loss position (<12 months) fair value?
- CVS Health (CVS) reported afs and trading securities - unrealized loss position (<12 months) fair value of $10.08B in Q1 2026.
- How has CVS Health's afs and trading securities - unrealized loss position (<12 months) fair value changed year-over-year?
- CVS Health's afs and trading securities - unrealized loss position (<12 months) fair value increased by 107.2% year-over-year, from $4.87B to $10.08B.
- What is the long-term trend for CVS Health's afs and trading securities - unrealized loss position (<12 months) fair value?
- Over 5 years (2020 to 2025), CVS Health's afs and trading securities - unrealized loss position (<12 months) fair value has grown at a 26.9% compound annual growth rate (CAGR), from $869.00M to $2.86B.